Stoneridge, Inc.
NYSE:SRIAuto - Parts
+$0.18 today
- Market cap
- $142.76M
- Beta
- 1.85
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$4.06
Volume 0.14M
Average 0.21M
SRI Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Stoneridge, Inc.NYSE: SRI
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development declines year over year
Q1 FY2026 research & development of $11.41M fell 35.1% year over year, behind the -25.1% change in trailing-twelve-month research & development. Sequentially, it fell 1.2% from the prior quarter. Over 3 fiscal years it compounded at -2.7% a year.
Context
- Research & development amounted to 7.0% of revenue in FY2025, down 1.0 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -35.1% toward the trailing-twelve-month pace of -25.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 60.21M USD
- Year-over-year change
- -16.6%
- 4-year CAGR
- -2.3%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 60.21M | -16.6% |
| FY2024 | 2024-12-31 | 72.17M | -19.7% |
| FY2023 | 2023-12-31 | 89.88M | +37.7% |
| FY2022 | 2022-12-31 | 65.3M | -1.3% |
| FY2021 | 2021-12-31 | 66.17M | — |
Research & Development vs competitors
How SRI compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -25.1% is the highest of 4, against a peer median of -98.6%.
- Research & development amounts to 6.7% of revenue for SRI, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $54.03M USD | -25.1% | -2.7% | 6.7% | |
| LTM Mar 2026 | $23.94M USD | — | +254.9% | — | |
| LTM Mar 2026 | $9.2M USD | -77.3% | +1.9% | 1.8% | |
AIIORobo.ai Inc. | FY2025 | $64K USD | -98.6% | -84.1% | 6.7% |
| LTM Feb 2026 | $0 USD | — | — | 0.0% | |
| LTM May 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | CN¥0 CNY | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding SRI) | — | -98.6% | +1.9% | 0.0% | |
Competitors are the stored peer set for SRI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 770.46M | 899.92M | 975.82M | 908.3M | 861.26M |
| Cost of Revenue | 603.6M | 725M | 773.72M | 719.04M | 697.22M |
| Gross Profit | 166.86M | 174.93M | 202.1M | 189.25M | 164.05M |
| Gross Margin | 21.7% | 19.4% | 20.7% | 20.8% | 19.0% |
| Research & Development | 66.17M | 65.3M | 89.88M | 72.17M | 60.21M |
| Selling, General & Admin | 116M | 106.7M | 114.07M | 117.46M | 115.68M |
| Operating Expenses | 151.45M | 171.99M | 189.26M | 189.63M | 175.88M |
| Depreciation & Amortization | 34.47M | 34.78M | 33.69M | 34.99M | 32.49M |
| EBITDA | 52.1M | 31.18M | 45.06M | 35.84M | (9.39M) |
| EBITDA Margin | 6.8% | 3.5% | 4.6% | 3.9% | -1.1% |
| Operating Income | 15.41M | 2.94M | 12.84M | (381K) | (11.84M) |
| Operating Margin | 2.0% | 0.3% | 1.3% | -0.0% | -1.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 5.19M | 7.1M | 13M | 14.45M | 13.58M |
| Other Income / Expenses | (2.98M) | (13.63M) | (14.76M) | (13.22M) | (43.61M) |
| Income Before Tax | 12.44M | (10.7M) | (1.92M) | (13.6M) | (55.45M) |
| Pre-Tax Margin | 1.6% | -1.2% | -0.2% | -1.5% | -6.4% |
| Income Tax Expense | 9.03M | 3.36M | 3.26M | 2.93M | 47.38M |
| Net Income | 3.41M | (14.06M) | (5.18M) | (16.52M) | (102.84M) |
| Net Margin | 0.4% | -1.6% | -0.5% | -1.8% | -11.9% |
| EPS (Basic) | 0.13 | (0.52) | (0.19) | (0.60) | (3.70) |
| EPS (Diluted) | 0.12 | (0.52) | (0.19) | (0.60) | (3.70) |
| Weighted Avg Shares | 27.11M | 27.26M | 27.28M | 27.6M | 27.8M |
| Weighted Avg Shares (Diluted) | 27.42M | 27.26M | 27.44M | 27.6M | 27.8M |
Stoneridge, Inc.
NYSE:SRI
Intrinsic Alpha fair value
Locked
Current Price
$5.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.